immun
toler
disrupt
lead
diseas
autoimmun
inflamm
furthermor
pathogeninduc
epigenet
immun
cell
may
implic
design
vaccin
strategi
could
lead
improv
vaccin
efficaci
epigenet
defin
herit
modif
dnachromatin
includ
chang
dna
sequenc
broader
term
howev
epigenet
describ
mechan
chromatinassoci
protein
posttransl
modif
ptm
histon
coval
modif
dna
regul
transcript
histon
code
hypothesi
propos
david
alli
colleagu
explain
singl
andor
combinatori
ptm
histon
defin
regul
transcript
state
dna
accord
hypothesi
histon
code
import
gene
express
dna
sequenc
develop
techniqu
chromatin
immunoprecipit
sequenc
recent
year
enabl
unpreced
advanc
understand
function
variou
histon
modif
gener
numer
enzym
contribut
establish
histon
modif
well
assort
effector
protein
bind
whether
histon
modif
truli
constitut
strict
code
clear
elabor
combin
ptm
histon
function
tightli
regul
celltypespecif
gene
transcript
arguabl
histon
modif
truli
epigenet
yet
understood
histon
modif
maintain
cell
divis
intergener
certainli
cell
immun
system
herit
induc
epigenet
modif
yet
demonstr
howev
function
pathogeninduc
epigenet
modif
particularli
cell
innat
immun
system
influenc
secondari
respons
differ
pathogen
short
term
week
month
least
aspect
discuss
detail
misexpress
mani
chromatinmodifi
enzym
increasingli
identifi
multipl
diseas
make
protein
write
eras
read
histon
tail
dna
modif
promis
intent
pursu
target
drug
discoveri
today
discuss
rapidli
accumul
evid
potenti
target
immunolog
diseas
enhanc
respons
pathogen
prevent
unwant
inflamm
epigenet
epi
outsid
regul
gene
express
dynam
process
establish
precis
cellular
develop
function
genet
ident
cell
regul
brought
coval
modif
dna
dnaassoci
histon
protein
dna
modif
primarili
cpg
methyl
hydroxyl
formyl
carboxyl
also
observ
eukaryot
cell
dna
packag
nucleu
along
histon
nonhiston
protein
collect
call
chromatin
unit
chromatin
nucleosom
consist
bp
nucleotid
wrap
around
histon
octam
histon
octam
contain
two
copi
histon
nucleosom
packag
progress
higherord
structur
ultim
give
rise
chromosom
visibl
light
microscop
metaphas
tail
histon
protein
protrud
nucleosom
subject
coval
chemic
modif
recent
mass
spectrometri
analysi
identifi
dozen
differ
type
ptm
histon
tail
studi
acetyl
methyl
phosphoryl
sumoyl
citrullin
ubiquitin
except
methyl
histonetail
modif
lead
chang
net
charg
nucleosom
loosen
interact
histon
dna
turn
affect
level
chromatin
compact
creat
condens
heterochromat
open
euchromat
region
refractori
permiss
respect
bind
tf
thu
histon
modif
lead
chang
chromatin
compact
affect
access
tf
promot
enhanc
region
thu
affect
gene
express
effect
histon
methyl
gene
express
larg
depend
posit
amino
acid
residu
methyl
whether
residu
mono
di
trimethyl
methyl
histon
lysin
associ
area
activ
transcript
wherea
methyl
associ
transcript
repress
dynam
natur
chromatin
modif
serv
key
requir
changeabl
gene
express
pattern
one
hand
histon
modif
stabli
maintain
amen
high
turnov
vari
modif
keep
chang
development
metabol
environment
need
delic
task
accomplish
sever
protein
tradit
divid
three
main
class
writer
establish
epigenet
modif
dna
histon
methyltransferas
histon
acetyltransferas
hat
kinas
etc
eras
remov
mark
demethylas
histon
deacetylas
hdac
phosphatas
reader
interpret
modif
dock
defin
protein
domain
bromodomain
chromodomain
plant
homeodomain
phd
fig
see
tabl
exampl
epigenet
enzym
reader
protein
also
shown
essenti
assembl
appropri
transcript
machineri
site
recognit
exampl
gene
promot
region
sum
histon
modif
determin
access
dna
tf
well
serv
site
recruit
transcript
machineri
specif
loci
sever
nuclear
process
nucleosom
occup
posit
along
dna
incorpor
altern
nonallel
histon
variant
promot
enhanc
region
express
bind
noncod
rna
long
noncod
rna
also
contribut
substanti
epigenet
regul
gene
express
variou
lysin
residu
along
ntermin
histon
tail
modifi
gain
methyl
ch
histon
lysin
methyl
one
modif
known
far
either
function
promot
eg
histon
lysin
repress
transcript
enzym
act
histon
methyltransferas
writer
demethylas
eras
collect
maintain
dynam
histon
methyl
landscap
methyl
key
role
regul
transcript
respons
innat
immun
cell
histon
demethylas
shown
util
jumonji
jmj
catalyt
domain
show
rapid
induct
respons
proinflammatori
stimuli
recruit
transcript
start
site
lipopolysaccharid
lp
induc
gene
thu
contribut
remov
repress
methyl
transcript
upregul
lpsinduc
gene
essenti
macrophag
polar
respons
helminth
infect
chitin
although
dispens
respons
histon
methyltransferas
catalyz
methyl
histon
lysin
methyl
found
subset
promot
lpsinduc
gene
rapidli
lost
follow
lp
stimul
similarli
dimethyl
level
type
interferon
ifn
ifn
stimulatori
gene
isg
invers
correl
scope
amplitud
ifn
isg
express
profession
ifnproduc
dendrit
cell
significantli
lower
level
dimethyl
gene
promot
compar
weak
produc
ifn
fibroblast
cardiac
myocyt
neuroblastoma
cell
inde
methyltransferas
knockout
fibroblast
show
enhanc
ifn
product
improv
abil
suppress
viru
repress
effect
dior
trimethyl
achiev
sever
mean
influenc
dna
methyl
heterochromatin
format
occlud
deposit
activ
histon
acetyl
activ
recruit
transcript
repressor
heterochromatin
protein
famili
signal
transduct
via
tolllik
receptor
tlr
immun
sensor
affect
permiss
histon
downstream
mainli
lysin
trimethyl
transcript
activ
promot
lysin
trimethyl
region
activ
transcript
least
two
immun
cell
type
show
enrich
activ
histon
mark
lpsinduc
fashion
dendrit
cell
stimul
lp
upregul
stabl
h
follow
stimul
except
loci
lowli
express
prestimul
becom
strongli
induc
stimul
similarli
macrophag
upregul
promot
enhanc
respect
multipl
gene
follow
exposur
rang
stimuli
major
acquir
return
basal
level
within
hour
histon
acetyl
revers
posttransl
modif
catalyz
hat
transfer
acetyl
moieti
acetylcoa
lysin
k
residu
hdac
catalyt
revers
process
lpsstimul
macrophag
show
increas
dc
dramat
acetyl
report
lp
time
cours
correl
rna
polymeras
ii
pol
ii
bind
histon
acetyl
exclus
read
bromodomain
bromodomaincontain
protein
human
genom
bromodomain
individu
protein
defin
affin
specif
locat
lysin
acetyl
shown
recruit
distinct
protein
chromatin
henc
subclass
bromodomain
protein
like
uniqu
function
regul
gene
express
work
focus
role
bromodomain
extratermin
bet
subfamili
bromodomaincontain
protein
consist
testesspecif
brdt
bet
protein
connect
histon
acetyl
state
transcript
elong
machineri
instanc
recruit
posit
transcript
elong
factor
b
ptefb
ctermin
domain
remov
paus
complex
neg
elong
factor
drb
sensitivityinduc
factor
thu
allow
transcript
elong
also
coactiv
transcript
activ
nfkb
via
specif
bind
acetyl
rela
knockdown
protein
howev
result
reduc
express
multipl
inflammatori
cytokin
macrophag
suggest
three
bet
protein
control
transcript
inflammatori
gene
lpsstimul
macrophag
like
abil
interact
polymeras
associ
factor
complex
chromatin
modifi
protein
role
incorpor
histon
variant
nonallel
form
convent
histon
gene
transcript
unclear
howev
emerg
pictur
presenc
variant
histon
protein
chromatin
confer
novel
structur
function
properti
nucleosom
context
immun
respons
ifn
treatment
shown
trigger
robust
incorpor
activ
gene
remain
even
cessat
transcript
interestingli
deposit
depend
histon
methyltransferas
wolfhirschhorn
syndrom
candid
interact
hira
histon
chaperon
inde
also
interact
ptefb
demonstr
deposit
histon
variant
facilit
transcript
elong
number
studi
describ
essenti
role
long
noncod
rna
lncrna
innat
immun
gene
express
fitzgerald
laboratori
identifi
highli
induc
lncrna
macrophag
dendrit
cell
follow
microbi
stimul
essenti
control
basal
level
isg
well
proinflammatori
cytokin
product
follow
microbi
challeng
mediat
repress
function
isg
interact
hnrnpab
knockdown
hnrnp
ab
result
decreas
level
rna
pol
ii
recruit
promot
macrophag
lncrna
also
shown
upregul
context
viral
infect
downstream
ifn
product
approxim
lncrna
differenti
express
follow
infect
sever
acut
respiratori
syndrom
coronaviru
influenza
lncrna
upregul
follow
treatment
human
hepatocyt
type
ifn
one
lncrna
potent
neg
regul
isg
knockdown
result
reduct
hepat
c
viru
replic
lncrna
also
shown
import
tlymphocyt
differenti
recent
chromatin
associ
lincrna
shown
specif
express
cell
express
invers
correl
tf
maf
express
cell
shown
modul
express
tran
recruit
chromatin
modifi
lsd
inde
downregul
shown
skew
tcell
differenti
toward
phenotyp
precis
kinet
innat
immun
cell
gene
transcript
follow
pathogen
assault
tightli
regul
chang
histon
modif
action
chromatin
remodel
complex
atpdepend
chromatinremodel
complex
influenc
transcript
statu
like
histon
modif
accomplish
slide
nucleosom
well
insert
eject
histon
octam
remodel
complex
classifi
four
famili
swisnf
chd
chromodomain
helicaselik
domain
iswi
includ
srcap
mammal
macrophag
preprogram
enabl
express
defin
set
primari
respons
gene
prg
within
minut
cell
activ
thought
accomplish
earli
naiv
macrophag
like
lineag
commit
enrich
activ
histon
tail
modif
commonli
found
promot
activ
transcrib
gene
eg
presenc
cpg
island
may
protect
repress
dna
methyl
well
high
level
rna
pol
ii
associ
thu
gene
requir
extens
chromatin
remodel
eg
swisnfmedi
chromatin
remodel
de
novo
protein
synthesi
activ
sinc
epigenet
prime
transcript
chromatin
state
permiss
swift
access
relev
tf
naiv
stage
prg
transcript
activ
low
level
produc
low
level
unsplic
unstabl
transcript
upon
appropri
stimul
gene
recruit
posit
elong
factor
ptefb
switch
express
matur
process
mrna
contrast
late
primari
respons
gene
secondari
respons
gene
srg
transcrib
hour
cell
stimul
possess
lowdens
cpg
promot
display
low
rna
pol
ii
occup
naiv
macrophag
requir
swisnf
complex
chromatin
remodel
transcript
take
place
innat
immun
system
histor
consid
perpetu
naiv
respect
immunolog
memori
thought
sole
featur
adapt
immun
system
howev
abil
rememb
respond
vigor
second
pathogen
encount
describ
organ
devoid
b
cell
inde
plant
invertebr
possess
adapt
immun
system
first
appear
evolut
jawless
earlyjaw
vertebr
howev
multipl
studi
demonstr
immun
system
plant
invertebr
prime
previou
infect
mount
stronger
recal
respons
upon
pathogen
rechalleng
exampl
innat
immun
antigenand
nonantigenspecif
memori
mammal
rapidli
emerg
innat
monocyt
neutrophil
mice
infect
attenu
listeria
monocytogen
capabl
bystand
kill
unrel
pathogen
leishmania
major
upon
secondari
infect
howev
prime
orchestr
primarili
inflammatori
mediat
produc
memori
cell
certainli
studi
shown
memori
cell
trigger
activ
innat
immun
cell
follow
reinfect
exampl
innat
immun
boost
mean
independ
adapt
immun
also
emerg
combin
aerosol
tlr
agonist
could
protect
mice
bacteri
pneumonia
influenza
infect
infect
heligmosomoid
polygyru
significantli
inhibit
type
diabet
nonobes
diabet
mice
mechan
human
shown
netea
laboratori
monocyt
recov
healthi
volunt
vaccin
bacillu
bcg
wide
use
live
attenu
vaccin
tuberculosi
produc
significantli
higher
level
inflammatori
cytokin
follow
exposur
nonmycobacteri
bacteria
fungi
importantli
nonantigenspecif
innat
immun
train
maintain
month
post
initi
vaccin
monocyt
immun
train
complet
independ
b
cell
sinc
sever
combin
immunodefici
mice
vaccin
week
prior
bcg
surviv
significantli
longer
lethal
inoculum
candida
albican
moreov
mice
protect
secondari
challeng
c
albican
lp
follow
prime
c
albican
find
suggest
train
innat
immun
cell
mammal
could
cell
intrins
least
independ
adapt
immun
system
epigenet
reprogram
initi
exposur
pathogen
appear
drive
train
innat
immun
cell
respond
differ
secondari
stimul
fig
recent
thought
celllineag
signalspecif
gene
express
program
fundament
predetermin
cellular
differenti
howev
recent
evid
demonstr
termin
differenti
cell
monocyt
macrophag
acquir
addit
histon
modif
upon
pathogen
exposur
affect
gene
express
upon
subsequ
stimul
activ
lp
induc
histon
modif
lead
alter
repress
gene
express
upon
secondari
lp
stimul
mani
pathogeninduc
epigenet
chang
macrophag
particularli
monomethyl
lysin
k
histon
enhanc
persist
despit
washout
stimulu
remov
tf
respons
initi
deposit
moreov
associ
faster
stronger
induct
multipl
gene
upon
nonspecif
restimul
c
abicansinduc
innat
immun
train
associ
chang
activ
certain
gene
promot
periton
macrophag
day
post
initi
infect
addit
methyltransferas
inhibitor
prevent
induc
train
followup
studi
group
show
cell
wall
compon
c
albican
could
induc
chang
well
human
monocyt
day
washout
without
direct
comparison
induc
acut
stimul
remain
difficult
interpret
whether
maintain
epigenet
modif
demonstr
activ
transcript
cell
trigger
mechan
nonetheless
mani
gene
alter
profil
week
c
albican
exposur
involv
innat
immun
signal
larg
proport
enhanc
associ
glycolysi
rais
interest
potenti
metabol
switch
innat
immun
train
multipl
epigenet
modif
wellestablish
link
central
metabol
histonemodifi
enzym
requir
metabolit
substrat
cofactor
demethylas
tet
protein
fe
ii
dioxegenas
hdac
naddepend
enzym
sadenosylmethionin
requir
function
dnahiston
methyltransferas
therefor
enzym
like
sensit
fluctuat
metabolit
interplay
metabol
epigenet
would
allow
rel
metabol
activ
cell
feed
back
transcript
regul
effort
maintain
homeostasi
fact
propos
epigenet
process
may
initi
mean
transduc
metabol
event
phenotyp
result
well
document
cancer
cell
undergo
switch
anaerob
metabol
warburg
effect
exhibit
multipl
epigenet
imbal
interestingli
macrophag
innat
immun
cell
frequent
found
inflam
site
character
low
oxygen
level
therefor
may
also
reli
heavili
relationship
metabol
epigenet
gene
express
certainli
activ
tlr
notabl
lead
switch
oxid
phosphoryl
glycolysi
immun
cell
succin
known
inhibit
fe
ii
depend
dioxygenas
histon
dna
demethylas
well
prolyl
hydroxylas
elev
inflamm
sustain
product
stabil
also
differenti
monocyt
macrophag
result
chang
abund
enzym
respons
peroxisom
pathway
glycin
serin
threonin
metabol
tricarboxyl
acid
cycl
monocyt
exhibit
reduc
oxygen
consumpt
enhanc
glucos
consumpt
increas
product
lactat
increas
nad
nadh
ratio
may
respons
observ
alter
cell
unknown
whether
pathogeninduc
epigenet
chang
maintain
life
infect
cell
daughter
cell
hematopoiet
stem
cell
truli
epigenet
innat
immun
memori
pathogen
infect
vivo
cell
innat
immun
system
gener
thought
short
live
howev
tissu
macrophag
shown
live
month
year
particularli
site
inflamm
tumor
prolifer
remain
unclear
demonstr
long
live
expect
train
immun
epigenet
metabol
mechan
import
consequ
design
vaccin
strategi
moreov
individu
histori
infect
may
influenc
function
innat
immun
system
least
short
term
alter
epigenet
coevolut
host
pathogen
driven
conflict
interest
akin
evolutionari
arm
race
host
interest
detect
stop
progress
infect
earli
mount
time
inflammatori
respons
convers
import
pathogen
subvert
innat
immun
system
ie
first
defens
respons
host
establish
infect
pathogen
must
also
prevent
excess
inflammatori
reaction
avoid
elimin
also
ensur
surviv
keep
host
aliv
end
pathogen
evolv
strategi
disrupt
host
immun
signal
cascad
culmin
drastic
transcript
upregul
sever
proinflammatori
immun
respons
gene
inhibit
nfkb
mapk
jakstat
signal
modul
protein
ubiquityl
welldocu
strategi
host
immun
evas
saw
earlier
proinflammatori
transcript
respons
formul
underli
complex
multistep
process
histon
modif
chromatin
remodel
elabor
natur
epigenet
control
provid
pathogen
substanti
opportun
manipul
host
gene
express
advantag
exampl
bacteria
epigenet
manipul
host
innat
immun
respons
nonpathogen
surviv
seen
mammalian
gut
commens
bacteria
essenti
inductionmainten
dna
methyl
gene
larg
intestin
epitheli
cell
result
reduc
express
thu
avoid
excess
inflammatori
reaction
pathogen
face
differ
select
pressur
commens
evolv
protein
interfer
interact
mimic
compon
host
epigenet
machineri
often
result
subvers
host
innat
immun
respons
broadli
achiev
chang
chromatin
architectur
three
way
influenc
host
histon
modif
use
host
epigenet
writer
enzym
interf
directli
enzym
host
chromatin
remodel
machineri
manufactur
protein
specif
recogn
host
histon
target
review
strategi
help
relev
exampl
next
tabl
l
monocytogen
infect
caus
drastic
global
dephosphoryl
deacetyl
accompani
repress
subset
proinflammatori
immun
gene
l
monocytogen
also
caus
histon
deacetyl
promot
isg
fact
heavili
reliant
host
infect
null
mutant
resist
l
monocytogen
infect
human
intestin
pathogen
shigella
flexneri
phosphatas
ospf
dephosphoryl
host
mapk
therebi
prevent
mapkdepend
phosphoryl
histon
select
gene
promot
make
inaccess
nfkbmediat
upregul
unknown
mechan
infect
toxoplasma
gondii
also
caus
loss
phosphoryl
acetyl
tnf
promot
result
impair
recruit
tf
pol
ii
bind
subsequ
inabl
cell
upregul
tnf
upon
lp
stimul
secondari
infect
mycobacterium
tuberculosi
counter
host
inflammatori
respons
repress
interferon
stimulatori
mhc
class
ii
hladr
transactiv
protein
ciita
downstream
mapk
signal
lead
bind
transcript
repressor
cebp
ciita
promot
region
keep
chromatin
remodel
complex
swisnf
ciitaregul
hladr
also
repress
promot
enrich
hdac
contain
chromatin
complex
interestingli
l
monocytogen
secretori
protein
lnta
directli
interact
chromatin
repressor
probabl
dislodg
isg
promot
caus
subsequ
upregul
isg
seemingli
counterintuit
strategi
propos
mechan
use
pathogen
fine
tune
host
ifn
ii
respons
infect
constitut
lnta
express
lead
faster
bacteri
clearanc
delet
heterozyg
mice
resist
infect
compar
wildtyp
sibl
sever
bacteri
pathogen
despit
lack
histon
higherord
chromatin
structur
produc
histonemodifi
protein
instanc
set
domaincontain
protein
roma
requir
pathogenesi
legionella
pneumonia
local
sever
gene
promot
includ
innat
immun
gene
promot
catalyz
previous
unreport
methyl
genomewid
lead
global
gene
repress
baset
bacillu
anthraci
requir
virul
methyl
lysin
residu
lead
repress
variou
nfkb
target
gene
promot
ankyrinrepeat
ank
contain
protein
yet
anoth
class
eukaryot
protein
mimic
found
intracellular
pathogen
anaplasma
ehrlichia
ricketssia
orientia
coxiella
legionella
speci
anaplasma
phagocytophilum
ticktransmit
pathogen
caus
human
granulocyt
anaplasmosi
propag
within
primari
antimicrobi
defens
cell
neutrophil
phagocytophilum
infect
lead
decreas
acetyl
subset
defens
gene
promot
overal
increas
express
consist
treatment
inhibitor
sever
restrict
bacterium
abil
surviv
host
suggest
pathogen
may
surviv
harsh
environ
host
cell
deacetyl
suppress
host
defens
gene
suggest
ankcontain
bacteri
secretori
protein
bind
atrich
chromatin
region
respons
hdac
recruit
relev
gene
promot
host
pathogen
employ
variou
type
molecular
mimicri
evad
host
immun
respons
recent
year
evid
pathogen
use
molecular
mimicri
host
histon
protein
modifi
transcript
respons
infect
emerg
carboxytermin
influenza
strain
protein
nonstructur
protein
share
resembl
histon
tail
tail
associ
polymeraseassoci
factor
transcript
elong
complex
well
chromatinremodel
complex
host
like
histon
tail
tail
bind
complex
unmodifi
lysin
methyl
upon
lysin
acetyl
bind
inhibit
elong
viral
induc
gene
presum
occlud
rna
pol
ii
associ
gene
bodi
fig
inde
mechan
specif
achiev
silenc
immun
proinflammatori
gene
set
host
well
understood
mani
exampl
cite
express
wide
array
gene
apart
immunerel
gene
affect
presum
broadrang
effect
epigenet
interfer
pathogen
may
face
elimin
far
host
system
fatal
perturb
autoimmun
diseas
character
loss
immunolog
toler
includ
greater
disord
affect
roughli
popul
nation
institut
health
nih
estim
million
american
suffer
autoimmun
diseas
preval
rise
genet
contribut
diseas
rang
simpl
mendelian
inherit
caus
allel
eg
mutat
loci
complex
interact
multipl
weak
loci
influenc
risk
rare
autoimmun
diseas
mendelian
inherit
pattern
within
famili
known
occur
exampl
autoimmun
polyendocrin
syndrom
type
immunodysregul
polyendocrinopathi
enteropathi
xlink
syndrom
autoimmun
lymphoprolif
syndrom
autoimmun
diseas
howev
multifactori
natur
suscept
control
multipl
genet
environment
factor
certainli
concord
rate
autoimmun
disord
monozygot
twin
rel
low
suggest
influenc
environment
like
epigenet
factor
autoimmun
pathogenesi
exposur
environment
factor
uv
tobacco
smoke
infecti
agent
well
femal
live
cold
climat
predispos
factor
autoimmun
epigenet
mechan
import
interfac
environment
stimuli
gene
express
thu
like
contributor
diseas
alter
posttransl
modif
histon
dna
methyl
two
major
epigenet
mechan
may
potenti
caus
breakdown
immun
toler
perpetu
autoimmun
diseas
inde
chang
dna
histon
modif
increasingli
observ
patient
autoimmun
diseas
correl
diseas
sever
thu
far
system
autoimmun
rheumat
diseas
like
system
lupu
erythematosu
sle
rheumatoid
arthriti
ra
receiv
focu
term
epigenet
regul
discuss
sle
perhap
moststudi
autoimmun
diseas
regard
epigenet
chronic
autoimmun
condit
affect
virtual
organ
system
sle
character
product
autoantibodi
target
varieti
nuclear
antigen
earli
studi
sle
demonstr
cell
treat
dna
methyl
inhibitor
convert
autoreact
introduct
synthet
demethyl
cell
mous
model
result
lupuslik
syndrom
subsequ
sever
studi
highlight
import
dna
methyl
sle
etiolog
sle
character
global
dna
hypomethyl
phenotyp
particularli
cell
b
cell
compar
healthi
control
furthermor
reduct
express
dna
methyltransferas
observ
sle
patient
compar
healthi
control
lead
overexpress
mani
gene
express
level
correl
diseas
sever
sle
promot
region
found
hypomethyl
sle
b
cell
monozygot
twin
ideal
model
studi
epigenet
influenc
contribut
autoimmun
process
one
recent
studi
compar
dna
methyl
genomewid
cohort
monozygot
twin
discord
sle
ra
dermatomyos
monozygot
twin
discord
sle
manifest
dna
methyl
express
chang
gene
relev
sle
pathogenesi
global
decreas
methyl
content
similarli
chang
histon
modif
associ
sle
state
global
hypoacetyl
hypomethyl
typic
cell
isol
sle
patient
shown
accompani
loss
lysin
methyltransferas
express
compar
healthi
control
fact
acetyl
level
invers
correl
sle
diseas
activ
histon
hypoacetyl
spleenisol
cell
lupuspron
mice
compar
control
murin
strain
carri
mutat
hat
develop
sever
lupuslik
diseas
serum
antidsdna
autoantibodi
glomerulonephr
prematur
death
furthermor
hdac
inhibitor
demonstr
improv
glomerulonephr
splenomegali
commonli
observ
sle
lastli
pbmc
patient
sle
show
disturb
express
sever
mirna
neg
regul
ifn
downregul
sle
patient
also
predict
sle
prognosi
also
control
regulatori
cell
treg
suppressor
function
treg
mediat
respons
express
reduc
sle
patient
shown
repress
protein
translat
moreov
overexpress
sever
mirna
shown
downregul
dnmt
express
cell
isol
sle
patient
culmin
global
hypomethyl
ra
chronic
system
inflammatori
diseas
primarili
affect
peripher
joint
clinic
onset
ra
requir
combin
genet
suscept
factor
deregul
immunomodul
well
environment
influenc
synovi
fibroblast
may
major
role
initi
perpetu
ra
certainli
alter
dna
methylom
signatur
synovi
fibroblast
deriv
ra
osteoarthr
patient
pbmc
ra
patient
healthi
control
well
reduc
amount
synovi
tissu
ra
patient
describ
variou
research
group
hypomethyl
gene
cluster
key
pathway
relat
cell
migrat
includ
focal
adhes
cell
adhes
transendotheli
migrat
extracellular
matrix
interact
review
dna
hypomethyl
derepress
retrotransposon
also
observ
cell
moreov
promot
region
death
receptor
gene
hypermethyl
ra
synovi
cell
result
reduc
express
protein
resist
apoptosi
interestingli
normal
fibroblast
treat
dna
methyltransferas
inhibitor
acquir
hypomethyl
activ
phenotyp
ra
monocyt
unmethyl
cpg
island
within
promot
region
associ
local
hyperactiv
inflamm
circuit
final
hypermethyl
promot
region
tf
key
gener
treg
also
report
ra
system
sclerosi
ra
synovi
tissu
evid
lower
hdac
activ
increas
express
methyltransferas
potenti
result
autoantibodi
target
found
ra
patient
treatment
ra
patient
antitumor
necrosi
factor
tnf
shown
increas
hathdac
ratio
nuclear
extract
pbmc
wherea
rituximab
increas
nuclear
activ
hat
hdac
recent
overexpress
aurora
kinas
aurka
b
aurkb
observ
mononuclear
cell
deriv
proteoglycaninduc
arthriti
pgia
mice
pbmc
deriv
treatment
naiv
ra
patient
compar
healthi
control
screen
known
chromatinmodifi
enzym
increas
aurka
aurkb
level
b
cell
deriv
pgia
mice
correl
elev
level
phosphoryl
histon
treatment
panaurora
kinas
inhibitor
promot
bcell
apoptosi
attenu
inflammatori
reaction
arthrit
mice
specif
express
function
mirna
particular
might
also
involv
ra
pathogenesi
multipl
sclerosi
ms
chronic
inflammatori
diseas
result
demyelin
neuron
subsequ
neurodegener
believ
immun
cell
attack
myelin
region
result
inflamm
disrupt
neural
signal
limit
data
epigenet
ms
reduct
report
methyl
rate
cytosin
cpg
island
white
matter
central
nervou
tissu
affect
individu
compar
control
increas
demethylas
enzym
activ
also
observ
howev
recent
comparison
multipl
epigenet
readout
cell
monozygot
twin
discord
ms
fail
identifi
consist
chang
dna
methyl
differ
methyl
approxim
million
cpg
dinucleotid
detect
sibl
three
twin
pair
nonetheless
determin
epigenet
base
ms
particular
import
search
better
therapeut
intervent
extens
studi
provid
wealth
evid
implic
genet
environ
factor
etiolog
new
case
famili
histori
moreov
diseas
incid
increas
past
decad
demonstr
data
finland
yearli
incid
increas
per
studi
epigenet
alter
howev
limit
monozygot
twin
discord
vari
loci
dna
methyl
addit
signific
increas
sever
highrisk
gene
includ
observ
peripher
lymphocyt
monocyt
patient
compar
normal
subject
tcellmedi
autoimmun
diseas
differenti
subtyp
helper
cell
govern
epigenet
factor
increas
bodi
weight
insulin
resist
may
associ
adult
addit
methyl
donor
methionin
cholin
cofactor
vitamin
folic
acid
pyridox
phosphat
essenti
dna
methyl
dietari
deriv
henc
conceiv
epigenet
mechan
associ
chang
nutrit
might
also
contribut
pathogenesi
support
hypothesi
hyperglycemia
observ
affect
histon
methyl
role
epigenet
modif
cancer
etiolog
progress
well
establish
direct
evid
dysregul
epigenet
landscap
chronic
immunebas
diseas
rapidli
emerg
studi
monozygot
twin
minim
confound
effect
genet
heterogen
diseas
etiolog
implic
epigenet
discord
diseas
affect
nonaffect
twin
inflamm
diseas
like
sle
asthma
genomewid
associ
studi
identifi
singl
nucleotid
polymorph
snp
chromatininteract
protein
signific
suscept
loci
inflammatori
diseas
variant
histon
reader
protein
associ
incid
crohn
diseas
ms
variant
within
dna
methyl
writer
crohn
diseas
histon
demethylas
ankylos
spondyl
three
snp
locu
found
associ
subset
ra
patient
posit
citrullin
peptid
cyclic
citrullin
peptid
independ
share
epitop
allel
addit
snp
locu
anoth
epigenet
reader
protein
name
shown
protect
joint
damag
progress
stage
genomewid
associ
studi
gwa
acpa
ra
patient
genet
mutat
autoimmun
regul
air
tf
affin
chromatin
marker
low
transcript
activ
identifi
caus
autoimmun
polyendocrinopathi
candidiasi
ectoderm
dystrophi
apec
also
call
rare
autosomalrecess
diseas
character
autoimmun
attack
peripher
tissu
well
gener
autoantibodi
patient
apec
carri
autoantibodi
serum
develop
multiorgan
autoimmun
display
variabl
symptom
prematur
gonad
failur
hypothyroid
enamel
hypoplasia
pernici
anemia
autoimmun
hepat
gastriti
alopecia
kerat
vitiligo
air
central
regul
neg
select
selfreact
cell
thymu
primarili
transcript
activ
air
induc
variabl
ectop
gene
express
subset
medullari
thymic
epitheli
cell
mtec
result
promiscu
express
normal
tissuerestrict
gene
thymu
mtec
present
protein
selfantigen
induc
clonal
delet
apoptosi
selfreact
thymocyt
lead
elimin
cell
would
otherwis
target
self
air
highli
express
mtec
critic
develop
selftoler
airedefici
mice
display
impair
clonal
delet
selfreact
thymocyt
lead
product
autoantibodi
lymphocyt
infiltr
peripher
tissu
air
compris
variou
protein
domain
caspaserecruit
domain
card
nuclear
local
signal
sand
air
nuclear
phosphoprotein
deform
epiderm
autoregulatori
factor
two
plant
homeodomain
phd
finger
card
domain
shown
critic
air
homooligomer
speckl
nuclear
local
phd
air
function
epigenet
reader
specif
recogn
unmethyl
lysin
histon
first
plant
homeodomain
shown
absolut
critic
air
transcriptiontransactiv
activ
well
capac
prevent
multiorgan
autoimmun
transgen
mous
model
recent
multipl
case
famili
monoallel
mutat
zinc
finger
air
follow
domin
inherit
identifi
typic
character
later
onset
milder
phenotyp
reduc
penetr
compar
classic
individu
biallel
diseasecaus
air
mutat
develop
classic
earlyonset
phenotyp
wherea
carri
one
three
differ
monoallel
mutat
finger
segreg
clear
vari
autoimmun
phenotyp
rang
lateonset
classic
isol
organspecif
autoimmun
eg
vitiligo
pa
autoantibodi
addit
disrupt
express
function
epigenet
enzym
immun
diseas
evid
diseaseassoci
mutat
enhanc
region
chromatin
recent
studi
found
major
autoimmun
diseas
gwa
variant
noncod
enrich
enhanc
region
activ
tcell
subpopul
enhanc
cisregulatori
element
dna
typic
hundr
base
pair
size
tf
cofactor
bind
control
transcript
activ
enhanc
select
mark
thu
genet
variant
regulatori
region
may
significantli
alter
bind
tf
gene
express
emphas
improp
epigenet
regul
may
lead
pathogenesi
autoimmun
diseas
fastevolv
understand
role
chromatin
modifi
enzym
dictat
precis
gene
transcript
program
homeostat
well
detriment
immun
inflamm
rais
excit
possibl
target
chromatinmodifi
enzym
combat
human
immunebas
diseas
tabl
target
epigenet
enzym
make
possibl
regul
subset
gene
similar
function
kinet
give
advantag
target
singl
inflammatori
cytokin
moreov
epigenet
modul
drug
current
fda
approv
cancer
could
potenti
leverag
repurpos
treat
autoimmun
patient
evid
epigenet
disrupt
outlin
previous
suppress
express
multipl
proinflammatori
gene
macrophag
studi
suggest
modul
eras
suppress
modif
demethylas
small
molecul
may
one
way
curtail
inflamm
howev
possibl
complic
fact
regul
proinflammatori
gene
may
independ
demethylas
activ
also
degre
sequenc
similar
among
jmjc
domain
histon
demethylas
made
unclear
small
molecul
inhibitor
could
exhibit
adequ
substrat
specif
glaxosmithklin
answer
challeng
identifi
highli
select
inhibitor
cellperm
lysinespecif
demethylas
utx
act
mimic
prevent
demethyl
repress
reduc
rna
pol
ii
recruit
prevent
transcript
tnf
inflammatori
cytokin
lpstreat
human
monocyt
interestingli
singl
knockdown
either
utx
reduc
tnf
suggest
demethylas
act
togeth
control
cytokin
transcript
hdac
phenylbutyr
human
subject
antiinflammatori
crohn
diseas
ulcer
coliti
saha
vpa
sulfat
sodiumand
trinitrobenzen
sulfon
acidinduc
coliti
mous
model
reduct
colon
preinflammatori
cytokin
product
decreas
sever
coliti
givinostat
human
subject
antiinflammatori
juvenil
idiopath
arthriti
saha
rodent
model
arthriti
antiinflammatori
rheumatoid
arthriti
phenylbutyr
tsa
adjuvantinduc
rat
arthriti
model
reduct
product
ra
affect
tissu
arthrit
score
human
ra
fibroblastlik
synoviocyt
adjuvantinduc
arthrit
mous
model
inhibit
cytokin
releas
caus
global
increas
acetyl
human
antiarthrit
rat
develop
inflamm
postinfect
kilham
rat
viru
reduct
virusinduc
inflamm
prevent
rat
model
autoimmun
prostat
mous
model
periodont
mous
model
arthriti
antiinflammatori
effect
hdac
human
pbmc
ra
patient
reduct
product
dosedepend
suppress
hdac
suppress
rat
develop
inflamm
postinfect
kilham
rat
viru
reduct
virusinduc
inflamm
prevent
histon
methyl
eras
utx
demethylas
primari
human
macrophag
reduct
lpsinduc
proinflammatori
cytokin
product
histon
acetyl
reader
bet
mous
bmdm
mous
model
bacteriainduc
sepsi
cell
differenti
experiment
autoimmun
encephalomyel
downregul
proinflammatori
gene
upon
lp
stimul
protect
endotox
shock
sepsi
inhibit
abil
cell
induc
neuroinflamm
vivo
mous
model
bacteriainduc
sepsi
reduct
protect
sepsi
vivo
mous
cell
patient
juvenil
idiopath
arthriti
antiinflammatori
protect
lpsinduc
death
inhibit
immunerel
superenhanc
diseaseassoci
gene
express
mous
model
hivassoci
nephropathi
rat
model
autoimmun
neuriti
prostiti
antiinflammatori
ex
vivo
cell
ankylos
spondyl
psoriat
arthriti
patient
healthi
control
reduct
recent
remain
unclear
histon
acetyl
activ
regul
transcript
passiv
byproduct
recent
eleg
singlecel
analys
reveal
histon
acetyl
gene
locu
alter
downstream
transcript
kinet
much
affect
two
tempor
distinct
event
first
acetyl
enhanc
search
kinet
transcript
activ
later
acetyl
acceler
transit
pol
ii
initi
elong
mammal
hdac
divid
three
class
basi
cellular
local
tissu
distribut
class
hdac
ubiquit
express
predominantli
nuclear
class
ii
hdac
nuclear
cytoplasm
express
certain
tissu
class
iii
hdac
also
call
sirtuin
nad
depend
enzym
although
success
use
treatment
cancer
research
suggest
target
certain
hdac
eras
could
util
treatment
inflammatori
diseas
asthma
ra
inflammatori
bowel
diseas
viru
infect
inde
variou
class
well
class
ii
hdac
target
inhibitor
like
trichostatin
tsa
vorinostat
suberanilohydroxam
acid
saha
phenylbutyr
givinostat
shown
antiinflammatori
effect
vitro
vivo
review
tabl
recent
shown
butyr
exposur
mous
colon
lamina
propria
macrophag
lead
increas
express
proinflammatori
mediat
tnf
increas
level
promot
region
gene
mous
bone
marrowderiv
macrophag
contrast
previous
describ
paninhibitor
hdac
specif
class
isoform
hdac
inhibitor
identifi
show
antiinflammatori
effect
anim
model
inflammatori
diseas
pbmc
ra
patient
respect
tabl
studi
use
new
even
potent
hdac
inhibitor
show
largazol
lar
marinederiv
class
hdac
inhibitor
suppress
express
intracellular
adhes
vascular
adhes
ra
synovi
fibroblast
wherea
activ
reduc
furthermor
author
show
lar
modul
express
level
indic
role
larinduc
chang
express
level
despit
reason
success
hdac
antiinflammatori
agent
exact
mode
epigenet
regul
antiinflammatori
agent
vivo
unclear
elucid
confound
fact
hdac
act
histon
nonhiston
substrat
hdac
inhibit
lead
gene
express
suppress
cell
contextdepend
manner
review
function
epigenet
reader
central
role
recruit
transcript
machineri
bet
famili
bromodomaincontain
protein
critic
express
multipl
gene
includ
involv
tumor
cell
growth
inflamm
make
attract
therapeut
target
moreov
target
epigenet
reader
seem
appeal
way
specif
interrupt
interpret
epigenet
modif
without
alter
overal
epigenet
landscap
cell
could
conceiv
occur
target
writer
eras
bromodomain
modul
share
conserv
fold
compris
lefthand
bundl
four
surround
central
acetyl
lysinebind
site
also
known
r
enantiom
identifi
initi
screen
upregul
upon
subsequ
chemoproteom
involv
immobil
compound
matrix
follow
affin
purif
interact
protein
cell
extract
liquid
chromatographytandem
mass
spectrometri
interact
protein
identifi
act
histon
mimic
competit
inhibit
bind
bet
protein
acetyl
histon
peptid
low
affin
toward
bromodomain
famili
member
make
specif
inhibitor
bet
subfamili
treatment
murin
bone
marrowderiv
macrophag
select
inhibit
activ
subset
lpsinduc
cytokin
chemokin
sever
tf
requir
inflammatori
respons
lpsinduc
ibetsuscept
gene
show
significantli
reduc
enrich
bet
protein
ptefb
pol
ii
demonstr
success
prevent
assembl
chromatin
activ
elong
promot
complex
promot
vast
major
gene
suppress
ibet
late
prg
srg
low
cpg
low
low
low
pol
ii
promot
naiv
macrophag
prg
housekeep
gene
high
cpg
high
high
could
inhibit
ibet
treatment
possibl
inabl
ibet
act
histon
mimic
outcompet
preexist
level
acetyl
loci
importantli
ibet
administr
mgkg
iv
also
prevent
lpsinduc
endotox
shock
bacteriainduc
sepsi
mice
highlight
potenti
antiinflammatori
agent
second
class
bet
famili
bromodomain
inhibitor
improv
pharmacokinet
also
shown
reduc
level
circul
protect
mice
lpsinduc
death
independ
studi
use
altern
panbet
inhibitor
also
observ
suppress
proinflammatori
cytokin
induct
rescu
mice
lpsinduc
death
final
murin
macrophag
compound
preferenti
target
first
bromodomain
block
transcript
activ
nfkbdirect
product
nitric
oxid
bet
famili
member
also
implic
replic
viral
genom
transcript
regul
multipl
viral
protein
exampl
compet
hiv
transactiv
protein
tat
ptefb
bind
result
repress
tatmedi
transactiv
hiv
promot
modul
hiv
transcript
associ
tf
bind
togeth
nfkb
hiv
enhanc
repress
hiv
transcript
suggest
bet
inhibitor
could
revers
hiv
latenc
awaken
latent
hiv
mean
viru
complet
erad
use
antivir
agent
suggest
bet
bromodomain
could
potenti
new
target
hiv
induct
strategi
treatment
naiv
cell
first
day
differenti
longlast
effect
subsequ
gene
express
cytokin
product
gene
express
analysi
reveal
upregul
express
sever
antiinflammatori
gene
product
includ
downregul
express
sever
proinflammatori
cytokin
includ
gmcsf
short
treatment
inhibit
abil
antigenspecif
cell
differenti
condit
vitro
induc
pathogenesi
adopt
transfer
model
experiment
autoimmun
encephalomyel
suppress
effect
tcellmedi
inflamm
vivo
accompani
decreas
recruit
macrophag
consist
decreas
gmcsf
product
cnsinfiltr
cell
effect
mimick
inhibitor
cmyc
function
implic
reduc
express
cmyc
gmcsf
one
avenu
suppress
inflammatori
function
cell
juvenil
idiopath
arthriti
jia
multifactori
autoimmun
diseas
associ
accumul
variou
immun
cell
includ
activ
memoryeffector
cell
joint
synovi
fluid
peeter
et
al
identifi
diseasespecif
inflammationassoci
typic
enhanc
superenhanc
signatur
jia
patient
synovi
fluidderiv
memoryeffector
cell
rna
sequenc
autoinflammatori
sitederiv
patient
cell
reveal
bet
inhibit
util
inhibit
immunerel
superenhanc
preferenti
reduc
diseaseassoci
gene
express
although
panbet
inhibitor
studi
show
great
preclin
promis
also
aid
investig
biolog
bromodomaincontain
protein
specif
bet
isoform
inhibitor
sole
target
brdt
may
eventu
requir
specif
indic
limit
side
effect
among
bromodomain
inhibitor
specif
inhibitor
bromodomain
protein
treatment
low
dose
reduc
secret
cell
ex
vivo
patient
ankolys
spondolyti
psoriat
arthriti
also
healthi
control
treatment
also
affect
express
narrow
rang
gene
compar
panbet
inhibitor
genet
factor
unabl
fulli
account
risk
prognosi
immun
diseas
epigenet
provid
import
link
genet
suscept
environ
develop
immunebas
diseas
moreov
field
epigenet
within
immunolog
rapidli
emerg
numer
studi
support
import
epigenet
initi
perpetu
immunebas
disord
illustr
recent
discoveri
new
class
chromatinmodifi
enzym
greater
insight
function
chromatinassoci
protein
immun
cell
find
mutat
gene
code
epigenet
machineri
immunebas
disord
develop
highli
potent
specif
small
molecul
inhibitor
epigenet
enzym
demonstr
potenc
immun
cell
moreov
idea
innat
immun
swiftli
chang
develop
concept
innat
immun
system
may
bear
memori
previou
pathogen
encount
mainten
alter
epigenet
pathogen
difficult
target
convent
vaccin
strategi
could
benefit
train
innat
immun
system
via
epigenet
manipul
still
unclear
whether
epigenet
alter
autoimmun
diseas
product
abnorm
immun
respons
lead
diseas
whether
alter
result
diseas
process
epigenet
modif
could
potenti
find
applic
biomark
take
individu
epigenet
variat
account
lead
better
precis
medicin
immun
diseas
futur
adjust
whole
subset
inflammatori
gene
rather
individu
inflammatori
mediat
druggabl
epigenet
enzym
would
better
serv
multitud
inflammatori
disord
current
lack
effect
therapi
futur
understand
plethora
epigenet
modifi
newli
develop
chemic
probe
well
ongo
document
epigenet
landscap
immun
cell
initi
blueprint
consortium
http
wwwblueprintepigenomeeu
nih
roadmap
epigenom
map
consortium
http
wwwroadmapepigenomicsorg
structur
genom
consortium
http
wwwthesgcorgepigenet
help
achiev
goal
